D. Fink

发表

Design and application of HSV vectors for neuroprotection

N. DeLuca, J. Glorioso, D. Wolfe, 2000, Gene Therapy.

Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

R. Ramakrishnan, J. Glorioso, R. Rouse, 1998, Gene Therapy.

Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo.

J. Glorioso, J. Goss, M. Mata, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.

S. Moriuchi, J. Cohen, D. Krisky, 1998, Cancer research.

cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo

R. Ramakrishnan, J. Glorioso, M. Schmidt, 1996, Journal of virology.

Rapid method for construction of recombinant HSV gene transfer vectors

R. Rouse, J. Glorioso, P. Marconi, 1997, Gene Therapy.

Engineering Herpes Simplex Virus Vectors for CNS Applications

J. Glorioso, W. Goins, S. Moriuchi, 1999, Experimental Neurology.

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications

R. Rouse, T. Oligino, J. Glorioso, 1998, Gene Therapy.

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

R. Ramakrishnan, P. L. Poliani, J. Glorioso, 1996, Proceedings of the National Academy of Sciences of the United States of America.

HSV as a gene transfer vector for the nervous system

N. DeLuca, J. Glorioso, W. Goins, 1995, Molecular biotechnology.

Gene transfer to brain using herpes simplex virus vectors

N. DeLuca, J. Glorioso, W. Goins, 1994, Annals of neurology.

Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system.

J. Glorioso, P. Poliani, D. Fink, 1997, Journal of neurovirology.

Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer

M. Mata, D. Wolfe, M. Chattopadhyay, 2007, Diabetologia.

Development and application of herpes simplex virus vectors for human gene therapy.

N. DeLuca, J. Glorioso, D. Fink, 1995, Annual review of microbiology.

Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR

R. Ramakrishnan, J. Glorioso, D. Fink, 1996, Journal of virology.

Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency.

V. Farutin, F. Wu, O. Makarova, 1996, Gene therapy.

A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats

J. Glorioso, W. Goins, L. Sternberg, 1994, Journal of virology.

Drug inducible transgene expression in brain using a herpes simplex virus vector

J. Glorioso, T. Oligino, J. Glorioso, 1998, Gene Therapy.

HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy

J. Glorioso, D. Fink, M. Mata, 2005, Gene Therapy.

Analysis of HSV-DNA and RNA Using the Polymerase Chain Reaction.

R. Ramakrishnan, M. Levine, D. Fink, 1998, Methods in molecular medicine.

Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion

H. H. Wu, J. Glorioso, W. Goins, 2001, Gene Therapy.

Gene transfer to neurons using herpes simplex virus-based vectors.

N. DeLuca, J. Glorioso, W. Goins, 1996, Annual review of neuroscience.

Gene therapy progress and prospects: Parkinson's disease

E. Burton, J C Glorioso, E A Burton, 2003, Gene Therapy.

Herpes simplex virus vectors for gene transfer to the nervous system.

R. Ramakrishnan, J. Glorioso, W. Goins, 1997, Journal of neurovirology.

Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.

R. Ramakrishnan, J. Glorioso, W. Goins, 1995, Clinical Neuroscience.

In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16.

M. Schmidt, J. Glorioso, P. Marconi, 1996, Gene therapy.

Herpes simplex virus vectors and gene transfer to brain.

N. DeLuca, J. Glorioso, W. Goins, 1994, Developments in biological standardization.